Cognitive deficits in Parkinson’s disease: A preliminary study of neuropsychological profiles
Objective: The purpose of this project was to examine cognitive deficits in a patient sample fulfilling the diagnostic criteria for idiopathic non-demented Parkinson's disease (PD)…Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment
Objective: We examined the effects of dopaminergic medication adjustment on cognitive function in Parkinson's disease (PD) patients without apparent dementia (Mini-Mental State Examination score of…Executive function and verbal fluency in patients with Parkinson’s disease
Objective: To determine whether the phonemic verbal fluency test is a purely cognitive measure or involves cognitive-motor interaction, if related to TMT. Background: Two of…Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia
Objective: The objective of this study was the identification of biochemical markers of cognitive impairment in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study
Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…Neuropsychological correlates of impulse control disorders and punding in Parkinson´ s disease
Objective: To investigate the relationship between cognitive deficits, Impulse Control Disorders (ICDs) and Punding in Parkinson's disease (PD). Background: The neuropsychological correlates of ICDs and…Applicability study of a multitask cognitive and motor exercise program for individuals with Parkinson´s disease: The COGWEB CNS Move Program
Objective: To test the applicability of a new rehabilitation program for people with Parkinson´s disease combining web-based cognitive training with motor exercises. Background: Parkinson´s disease…High frequency of mutations in the glucocerebrosidase (GBA) gene among Ashkenazi Jews with dementia with Lewy bodies
Objective: The objective of this study was to characterize, clinically and genetically, anAshkenazi Jewish cohort of patients diagnosed with DLB, looking for the association with…Influence of motor manifestation and onset’s side on the spectrum of non-motor symptoms in patients with Parkinson’s disease
Objective: To analyze Parkinson's disease (PD) motor manifestation and onset's side influence on the spectrum of non-motor symptoms (NMS). Background: Possibly the onset's side and…Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson’s disease
Objective: To investigate whether cerebrospinal fluid (CSF) levels of tau, phosphorylated tau, β-amyloid42, α-synuclein, neurofilament light and YKL-40 change over time and if changes correlate…
- « Previous Page
- 1
- …
- 115
- 116
- 117
- 118
- 119
- …
- 128
- Next Page »
